Tixagevimab Terminated Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT05438498Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2